Ir >>   
Uds: 0
Importe: 0,00
Tengo un usuario, deseo validarme - regístrate
  Buscar/Pesquisa        Búsqueda avanzada  
Herramienta de traducción gratuita de páginas web
 > Libros de Medicina  > Medicina Interna  > Reumatología  - Llámanos (+34) 913788918 ¡Gasto de envío gratis para pedidos superiores a 100€ (sin iva) en Península!
Scleroderma, From Pathogenesis To Comprehensive Management
Scleroderma, From Pathogenesis To Comprehensive Management
Autores: John Varga; Christopher P. Denton; Fredrick M. Wigley
ISBN: 9781441957733
Formato: Rústica/Paperback
Nº volumenes: 1 Páginas: 689
Año publicación/Ano de publicação: 2012
Disponibilidad/Disponibilidade: 15 días
Precio/Preço : 209,95 € 207,43 € (199,45€ + iva)
 (Sea el primero en opinar ) ¿Vas a pedir más de 5 productos? Escríbenos, te enviaremos presupuesto ajustado, envíanos mail

Cómpralos juntos y ahorra
Scleroderma, From Pathogenesis To Comprehensive Management La Fibromialgia +DVD
· Scleroderma, From Pathogenesis To Comprehensive Management (John Varga; Christopher P. Denton; Fredrick M. Wigley)
· La Fibromialgia +DVD (Maria Isabel, Heraso)
228,13 € 216,72 €
■Easily accessible, clear and concise format
■Presents an integrated multidisciplinary approach to comprehensive patient care
■Includes a synthesis of current concepts in pathogenesis and pathomechanics
■Authoritative work from international leaders specializing in the field
This essential resource presents the most up-to-date information on scleroderma. A clear and concise synthesis of current concepts in pathogenesis and modern approaches to management, this book is comprised of the authoritative work of international experts. With an integrated multidisciplinary approach to comprehensive care, this book is easily accessible for health care professionals in many fields. It is a valuable resource for rheumatologists, pulmonologists, cardiologists, gastroenterologists, nephrologists and all those involved in the care of scleroderma patients.

Content Level » Professional/practitioner
Keywords » Autoimmune - Fibrosis - Pulmonary Hypertension - Sclerodoma - Systemic sclerosis
Related subjects » Internal Medicine - Rheumatology

Stephen Katz MD, PhD, Director, NIAMS
A personal view: Luke Evnin, PhD, President, SRF
John Varga, MD, Christopher P. Denton, PhD, FRCP, Fredrick M. Wigley, MD
■Section I. Introduction
■Chapter 1 – Historical Perspective – Christopher P. Denton, PhD, FRCP, and Carol Black
■Chapter 2 - Therapeutic evolution: a professor’s view – Frank A. Wollheim, MD, PhD, FRCP
■Section II: Epidemiology, Genetics and Classification
■Chapter 3 – Overview: Epidemiology, Genetics and Classification – Christopher P. Denton, PhD, FRCP
■Chapter 4 – Epidemiology and Environmental Risk Factors – Jammie K. Barnes, MD, and Maureen D. Mayes, MD, MPH
■Chapter 5 – Genetic Factors – Yannick Allanore, MD, PhD, and Filemon K. Tan, MD, PhD
■Chapter 6 – Disease Subsets in Clinical Practice – Robyn Therese Domsic, MD, MPH,and Thomas A. Medsger, Jr., MD
■Chapter 7 – Evolving Concepts of Diagnosis and Classification – Lorinda Chung, MD, MS, Jaap Fransen, MD, and Frank H.J. Van den Hoogen, MD, PhD
■Chapter 8 – Disease Classification using Molecular Signatures – Michael L. Whitfield, PhD, and Robert Lafyatis, MD
■Section III: Scleroderma in Children
■Chapter 9 – Juvenile Localized Scleroderma – Francesco Zulian, MD
■Chapter 10 - Juvenile Systemic Scleroderma - Ivan Foeldvari, MD
■Section IV: Other Fibrosing Skin Conditions
■Chapter 11 – Scleroderma Mimics –Laura K. Hummers, MD, ScM
■Chapter 12 - Localized Forms of Scleroderma in Adults – Amy E. Gilliam, MD, and Anita C. Gilliam, MD, PhD
■Chapter 13 - Nephrogenic Systemic Fibrosis – Peter J. Wermuth, PhD, and Sergio A. Jimenez, MD
■Section V: Pathogenetic Basis
■Chapter 14 - Overview: Integrated Pathogenesis – John Varga, MD
■Chapter 15 - Immunological Mechanisms – Francisco Boin, MD, and Carlo Chizzolini, MD
■Chapter 16 - Innate Immunity – Keith B. Elkon, MD, and Julia J. Rhiannon, MD, MSW
■Chapter 17 – Autoantibodies in Pathogenesis – Kimberly Doering, BS, and Antony Rosen, MB ChB, BSc (Hons)
■Chapter 18 - The Clinical Aspects of Autoantibodies - John D. Pauling, BMBS, MRCP, and Neil McHugh, MB, ChB, MD, FRCP, FRCPath
■Chapter 19 – Mechanisms of Vascular Disease – Bashar Kalaheh, MD, and Mary Jo Mulligan-Kehoe, PhD
■Chapter 20 - Vascular Biomarkers – Laura K. Hummers, MD, ScM
■Chapter 21 – Mechanisms of Fibrosis – John Varga, MD
■Chapter 22 – Fibrosis: Insights from the stiff skin syndrome – Elizabeth E. Gerber, BS, and Harry C. Dietz, MD
■Chapter 23 - Biomarkers of Fibrosis – Christian Beyer, MD, Oliver Distler, MD, and Jörg H.W. Distler, MD
■Chapter 24 – Overview of Animal Models – Christopher P. Denton, PhD, FRCP, and Robert Lafyatis, MD
■Section VI: Cardiovascular Manifestations and Management
■Chapter 25 – Overview: Cardiovascular Manifestations and Management – Fredrick M. Wigley, MD
■Chapter 26 – Raynaud Phenomenon – Arianne Herrick and Fredrick M. Wigley, MD
■Chapter 27 – Nailfold Capillaroscopy – Maurizio Cutolo, MD and Vanessa Smith, MD, PhD
■Chapter 28 – SystemicVascular Disease , MD, PhD, MD, FRCP
■Chapter 29 – Scleroderma Renal Crisis – Christopher P. Denton, PhD, FRCP, and Virginia Steen, MD
■Chapter 30 – Cardiac Involvement –Sanjiv J. Shah, MD, and André Kahan, MD, PhD
■Chapter 31 – Erectile Dysfunction – Edward V. Lally, MD, Arthur L. Burnett, MD, MBA, FACS, and Trinity J. Bivalacqua, MD, PhD
■Section VII: Pulmonary manifestations and management
■Chapter 32 – Overview: Pulmonary manifestations and management – Christopher P. Denton, PhD, FRCP
■Chapter 33 – Clinical Assessment of Lung Disease – Greg J. Keir, MBBS, FRACP, Richard M. Silver, MD, and Athol U. Wells, MD, FRCP
■Chapter 34 – Computerized Tomography of Interstitial Lung Disease – Athol U. Wells, MD, FRCP, and Jonathan Goldin MD, PhD, FRCR
■Chapter 35 – Treatment of interstitial lung disease – Dinesh Khanna, MD, MS, and Donald P. Tashkin, MD
■Chapter 36 – Clinical Assessment of Pulmonary Hypertension – Harrison W. Farber, MD, Michael York, MD, Eric Hachulla, MD, PhD
■Chapter 37 – Treatment of Pulmonary Hypertension –Todd H. Kolb, MD, PhD, and Paul M. Hassoun, MD
■Chapter 38 – Complex Challenges of Pulmonary Hypertension – John Gerard Coghlan, MD, FRCP
■Section VIII: Gastrointestinal manifestations and management
■Chapter 39– Overview: Gastrointestinal Manifestations and Management - Seth Sweetser, MD, and Michael Camilleri, MD
■Chapter 40 – Upper Gastrointestinal Tract - John O. Clarke, MD, and Ikuo Hirano, MD
■Chapter 41 – Small and Large Intestinal Involvement - Philip J. Clements, MD, MPH, Terri R. Getzug, MD, and Dinesh Khanna, MD, MS
■Section XIX: Skin, musculoskeletal and other complications
■Chapter 42 - Evaluation and Management of Skin Disease – Noëlle Starr Sherber, MD, FAAD
■Chapter 43 – Skeletal Muscle Involvement – Andrew L. Mammen, MD, PhD
■Chapter 44 - Tendons, Joints and Bone – Jérôme Avouac, MD, PhD, and Yannick Allanore, MD, PhD
■Chapter 45 – Pregnancy – Virginia Steen, MD, and Eliza F. Chakravarty, MD, MS
■Chapter 46 - Overlooked Manifestations– Ami A. Shah, MD, MHS
■Section X: Disease-modifying strategies
■Chapter 47 –Principles of ManagementD. , MD, MPH
■Chapter 48 - Immunomodulatory Therapies – Jacob M. van Laar, MD, PhD
■Chapter 49 - Cell-Based Therapies – Alan G. Tyndall, MD, FRACP, Rheumatology FMH, and Keith M. Sullivan, MD
■Chapter 50 - Investigative Approaches to Drug Therapy – Voon H. Ong, PhD, MRCP, and Christopher P. Denton, PhD, FRCP
■Chapter 51 – Complementary and alternate medicine approaches – Judy A. Fulop, MD, MS, FABNO, and John Varga, MD
■Chapter 52 - Physical and occupational therapy– Luc Mouthon, MD, PhD, and Janet L. Poole, PhD, OTR/L
■Chapter 53 – Evaluation and Management of Psychosocial Issues – El-Baalbaki Ghassan, PhD, Lisa Jewett, BA, MSc, Jennifer A. Haythornthwaite, PhD, and Brett D. Thombs, PhD
■Section XI: Outcome assessment
■Chapter 54 - Issues in Clinical Trial Design– Suzanne Kafaja, MD, Daniel E. Furst, MD, and Janet E. Pope, MD, MPH, FRCPC
■Chapter 55 - Measuring Disease Activity– Dinesh Khanna, MD, MS
■Chapter 56 – Patient Reported Outcomes – Monique Hinchcliff, MD, and David Cella, PhD
Lo más vendido este mes/Os mais vendidos este mês
Harrison Principios De Medicina Interna, 2 Vols. + Vídeos Online 19ª Ed.
Loscalzo | Jameson | Fauci | Kasper
200,00 €
Farreras Y Rozman Medicina Interna, 2 Vols. 18ª  Ed.
Elsevier España, 2016
F. Cardellach | C. Rozman
200,00 €
Manual de pediatría 3ed
Ergón, 2013
Juan A. Molina Font | Rafael Jiménez González | Juan Brines Solanes | Manuel Crespo Hernández | Manuel Cruz Hernández
59,85 €
Medimecum 2015. Guía de terapia farmacológica
Adis International, 2015
Varios Autores
33,57 €
Medimecum 2016. Guía de terapia farmacológica
Adis International, 2016
Varios Autores
33,55 €
Harrison Principios De Medicina Interna, 2 Vols. + Dvd 19ª Ed.
Eugene Braunwald | Anthony Fauci | Dennis L. Kasper
200,00 €
Guía Sanford De Terapéutica Antimicrobiana 2016 46ª Ed.
21,93 €
Manual De Consulta Externa De Medicina Interna
Aula Médica, 2016
Isaac Mora Escudero | Javier Solera Santos
38,37 €
Diagnóstico diferencial en medicina interna. De los síntomas al diagnóstico
161,00 €
Si desea suscribirse a nuestros boletines gratuitos por favor regístrese como usuario.
Atención clientes
Para realizar sus pedidos o consultas relacionadas con productos llame al:
(+34)91 378 89 18


Acerca de los certificados SSL
Nosotros subscribimos Los Principios del código HONcode de la Fundación Salud en la Red Nosotros subscribimos los Principios del código HONcode. Compruébelo aquí.